NDC 69683-101

DERMOSCRIBE ICHYBUM

Hydrocortisone, Clioquinol, Zinc Oxide

DERMOSCRIBE ICHYBUM is a Topical Cream in the Human Otc Drug category. It is labeled and distributed by Dermoscribe Pty Ltd. The primary component is Clioquinol; Hydrocortisone.

• Product ID: 69683-101_d60d9880-5362-ff88-e053-2995a90a2ecd
• NDC: 69683-101
• Product Type: Human Otc Drug
• Proprietary Name: DERMOSCRIBE ICHYBUM
• Generic Name: Hydrocortisone, Clioquinol, Zinc Oxide
• Dosage Form: Cream
• Route of Administration: TOPICAL
• Marketing Start Date: 2015-03-23
• Marketing Category: OTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL
• Application Number: part348
• Labeler Name: DERMOSCRIBE PTY LTD
• Substance Name: CLIOQUINOL; HYDROCORTISONE
• Active Ingredient Strength: 1 g/100g; g/100g
• Pharm Classes: Allergens [CS], Cell-mediated Immunity [PE], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 69683-101-11

28 g in 1 BOTTLE (69683-101-11)

• Marketing Start Date: 2015-03-23
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 69683-101-11 [69683010111]

DERMOSCRIBE ICHYBUM CREAM

• Marketing Category: OTC monograph not final
• Application Number: part348
• Product Type: HUMAN OTC DRUG
• Marketing Start Date: 2015-03-23

Drug Details

Active Ingredients

Ingredient	Strength
HYDROCORTISONE	1 g/100g

OpenFDA Data

• SPL SET ID: 134a88a1-13e5-4da0-8270-c380b57aaeb7
• Manufacturer:
  • XLMA PTY LTD
• UNII:
  • 7BHQ856EJ5
  • WI4X0X7BPJ
• RxNorm Concept Unique ID - RxCUI:
  • 1606483